A new era of psychedelic medicine
Novamind is building the infrastructure required for a regulated psychedelics industry
Why psychedelics?
“Psychedelics, used responsibly and with proper caution, would be for psychiatry what the microscope is for biology or the telescope is for astronomy.”
— Stanislav Grof, MD
At the forefront of mental healthcare innovation
We are dedicated to advancing psychedelic research and catalyzing personal wellness.
Read about usOur missionTo facilitate safe, legal access to psychedelics.
Our visionA new standard of mental healthcare.
Press releases
View allNovamind to Participate in MAPS Canada Webinar on Eating Disorders and PTSD
November 24, 2020
Novamind Closes Oversubscribed CAD$10 Million Private Placement
November 23, 2020
Novamind and Hinterland Metals Enter into Amalgamation Agreement
November 17, 2020
Novamind Supports Oregon Measure 109 to Responsibly Expand Patient Access to Psilocybin Therapy
November 10, 2020
